Back

Select your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Arrange a consultation about stem cells

Learn more

Get in touch with us today!

Would you like to find out more about our services? Fill out the form below and we will contact you as soon as possible to provide you with all the necessary information and answer your questions.

    We would like to point out that the personal data provided in the form will be processed by FamiCord Suisse, based in Switzerland (BusinessPark Zug Sumpfstrasse 26, 6302 Zug), for the purpose of contacting you by telephone in connection with the provision of service information.

    Image

    List of
    transplantations

    List of uses for stem cells approved by the FamiCord Group’s laboratories:

    Image
    List of uses for stem cells approved by the FamiCord Group’s laboratories:
    Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
    901 Apheresis Autologous Central nervous system lymphoma Hematology 2025 Standard Therapy Germany 70
    902 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 61
    903 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 54
    904 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 41
    905 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 32
    906 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 72
    907 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Poland 52
    908 Apheresis Allogeneic Chronic Myeloid Leukemia Hematology 2025 Standard Therapy Poland 50
    909 Apheresis Allogeneic T-cell Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 17
    910 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 66
    911 Apheresis Allogeneic Multiple Myeloma Hematology 2025 Standard Therapy Poland 49
    912 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2025 Standard Therapy Poland 5
    913 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 55
    914 Apheresis Allogeneic Diffuse Large B-cell Lymphoma Hematology 2025 Standard Therapy Poland 68
    915 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 64
    916 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 51
    917 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 58
    918 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 65
    919 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 61
    920 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 65
    921 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 19
    922 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 65
    923 Apheresis Allogeneic Mixed Phenotype Acute Leukemia Hematology 2025 Standard Therapy Poland 47
    924 Apheresis Allogeneic Polycythemia Vera Hematology 2025 Standard Therapy Poland 61
    925 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 56
    926 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 53
    927 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 55
    928 Apheresis Allogeneic Myelodysplastic Syndrome, Myeloproliferative Neoplasms Hematology 2025 Standard Therapy Poland 34
    929 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 50
    930 Apheresis Allogeneic Myelodysplastic Disorders Hematology 2025 Standard Therapy Poland 71
    931 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy Poland 64
    932 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 54
    933 Apheresis Autologous Non-Hodgkin lymphoma Hematology 2025 Standard Therapy Germany 50
    934 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 50
    935 Apheresis Allogeneic Acute myeloid leukemia Hematology 2025 Standard Therapy Germany 35
    936 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 54
    937 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 52
    938 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 61
    939 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 55
    940 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 64
    941 Apheresis Autologous Central Nervous System Lymphoma Hematology 2025 Standard Therapy Germany 68
    942 Apheresis Allogeneic Primary myelofibrosis Hematology 2025 Standard Therapy Germany 71
    943 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 47
    944 Apheresis Autologous Central Nervous System Lymphoma Hematology 2025 Standard Therapy Germany 58
    945 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 68
    946 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Portugal 44
    947 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Portugal 59
    948 Apheresis Autologous Lymphoma Non-Hodgkin Hematology 2025 Standard Therapy Portugal 58
    949 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Sweden 59
    950 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 2
    951 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 41
    952 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy France 48
    953 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Sweden 64
    954 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy United Kingdom 63
    955 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 64
    956 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 58
    957 Apheresis Allogeneic Myelodysplastic Syndrome, Myeloproliferative Neoplasms Hematology 2025 Standard Therapy Poland 68
    958 Apheresis Allogeneic Myelodysplastic Syndrome, Myeloproliferative Neoplasms Hematology 2025 Standard Therapy Germany 59
    959 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 56
    960 Apheresis Allogeneic Diffuse Large B-cell Lymphoma Hematology 2025 Standard Therapy Belarus 53
    961 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 60
    962 Apheresis Allogeneic Immunodeficiency – LRBA Hematology 2025 Standard Therapy Turkey 14
    963 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Poland 20
    964 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 65
    965 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Ukraine 54
    966 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 75
    967 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 58
    968 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 48
    969 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 37
    970 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Chile 40
    971 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 72
    972 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Switzerland 65
    973 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy Portugal 68
    974 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Estonia 9
    975 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 63
    976 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Sweden 67
    977 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Lithuania 45
    978 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 59
    979 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 69
    980 Apheresis Autologous T-cell lymphoma Hematology 2025 Standard Therapy Germany 64
    981 Apheresis Allogeneic Acute lymphoblastic leukemia Hematology 2025 Standard Therapy Germany 42
    982 Apheresis Autologous Primary central nervous system lymphoma Hematology 2025 Standard Therapy Germany 64
    983 Apheresis Allogeneic Myelodysplastic Syndrome/ Acute Myeloid Leukemia Hematology 2025 Standard Therapy Germany 62
    984 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 42
    985 Apheresis Autologous T-cell lymphoma Hematology 2025 Standard Therapy Germany 55
    986 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 72
    987 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 58
    988 Apheresis Autologous Central nervous system lymphoma Hematology 2025 Standard Therapy Germany 65
    989 Apheresis Autologous Follicular lymphoma Hematology 2025 Standard Therapy Germany 67
    990 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 70
    991 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 60
    992 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Portugal 64
    993 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Portugal 63
    994 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 67
    995 Apheresis Autologous Acute myeloid leukemia Hematology 2025 Standard Therapy Germany 60
    996 Apheresis Autologous Hodgkin lymphoma rezidiv Hematology 2025 Standard Therapy Germany 65
    997 Apheresis Autologous Non-Hodgkin lymphoma Hematology 2025 Standard Therapy Germany 64
    998 Apheresis Autologous T-cell lymphoma Hematology 2025 Standard Therapy Germany 67
    999 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 70
    1000 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 62